DAVID ZACCARDELLI - 29 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role: President and CEO, Director
Signature: /s/ Andrew Fisher, Attorney-in-fact for David Zaccardelli
Issuer symbol: VRNA
Transactions as of: 29 Aug 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Sep 2025, 16:32:00 UTC
Previous filing: 05 Aug 2025
Next filing: 08 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ZACCARDELLI DAVID	President and CEO, Director	3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM	/s/ Andrew Fisher, Attorney-in-fact for David Zaccardelli	03 Sep 2025	0001627642

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRNA	Ordinary Shares	Gift	$0	-1,200,000	-9%	$0.000000	12,176,144	29 Aug 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2	Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 9,801,144 Ordinary Shares underlying 1,225,143 ADSs.